Efavirenz

Results: 509



#Item
1Therapeutic Drug Monitoring Immunoassay for Efavirenz Kenneth C. Kasper1, Joanne Valencia1, Ki Chung1, Byung Sook Moon1, Johnny Valdez1, Anura Jayewardene2, Patricia Lizak2, and Francesca T. Aweeka2 ARK Diagnostics, Inc.

Therapeutic Drug Monitoring Immunoassay for Efavirenz Kenneth C. Kasper1, Joanne Valencia1, Ki Chung1, Byung Sook Moon1, Johnny Valdez1, Anura Jayewardene2, Patricia Lizak2, and Francesca T. Aweeka2 ARK Diagnostics, Inc.

Add to Reading List

Source URL: www.ark-tdm.com

Language: English - Date: 2012-10-03 00:11:29
    2The ARK EFV-TestTM: A Rapid, Automated Immunoassay for Therapeutic Drug Monitoring of Efavirenz Michael K. Helms1, Diane T. Holland2, Rowena J. Espina-Quinto2, Ellen K. Stefanski2, Byung S. Moon1, Johnny J. Valdez1, and

    The ARK EFV-TestTM: A Rapid, Automated Immunoassay for Therapeutic Drug Monitoring of Efavirenz Michael K. Helms1, Diane T. Holland2, Rowena J. Espina-Quinto2, Ellen K. Stefanski2, Byung S. Moon1, Johnny J. Valdez1, and

    Add to Reading List

    Source URL: www.ark-tdm.com

    Language: English - Date: 2012-10-03 00:11:04
      3BMS_Gilead_Logo_FINAL.eps

      BMS_Gilead_Logo_FINAL.eps

      Add to Reading List

      Source URL: packageinserts.bms.com

      Language: English - Date: 2016-03-03 11:54:31
      4Patient Information ATRIPLA® (uh TRIP luh) Tablets ALERT: Find out about medicines that should NOT be taken with ATRIPLA. Please also read the section

      Patient Information ATRIPLA® (uh TRIP luh) Tablets ALERT: Find out about medicines that should NOT be taken with ATRIPLA. Please also read the section "MEDICINES YOU SHOULD NOT TAKE WITH ATRIPLA." Generic name: efaviren

      Add to Reading List

      Source URL: packageinserts.bms.com

      Language: English - Date: 2016-02-18 16:31:16
      5SUPPLEMENT ARTICLE Drug-Drug Interactions in the Treatment of HCV Among People Who Inject Drugs Stefan Mauss1 and Hartwig Klinker2 1

      SUPPLEMENT ARTICLE Drug-Drug Interactions in the Treatment of HCV Among People Who Inject Drugs Stefan Mauss1 and Hartwig Klinker2 1

      Add to Reading List

      Source URL: www.hepatitis-c-initiative.eu

      Language: English - Date: 2014-07-02 11:51:22
      6ANTIRETROVIRAL PRIORITIES OF THE MEDICINES PATENT POOL

      ANTIRETROVIRAL PRIORITIES OF THE MEDICINES PATENT POOL

      Add to Reading List

      Source URL: www.medicinespatentpool.org

      Language: English - Date: 2015-04-20 05:17:21
      71 DECEMBER Correspondence HIV-1 Genotypic DrugResistance Interpretation Algorithms Need to Include HypersusceptibilityAssociated Mutations

      1 DECEMBER Correspondence HIV-1 Genotypic DrugResistance Interpretation Algorithms Need to Include HypersusceptibilityAssociated Mutations

      Add to Reading List

      Source URL: www.ram.org

      Language: English - Date: 2015-04-27 23:15:34
      8AIDS Research and Therapy BioMed Central Research

      AIDS Research and Therapy BioMed Central Research

      Add to Reading List

      Source URL: www.aidsrestherapy.com

      Language: English
      9This is an electronically controlled document. User is responsible to verify and use the current revision. GENERAL CONFORMITY CERTIFICATE Pursuant to 15 U.S.C. § 2063(a), Gilead Sciences, Inc. certifies that based on a

      This is an electronically controlled document. User is responsible to verify and use the current revision. GENERAL CONFORMITY CERTIFICATE Pursuant to 15 U.S.C. § 2063(a), Gilead Sciences, Inc. certifies that based on a

      Add to Reading List

      Source URL: gilead.com

      Language: English - Date: 2013-02-25 18:48:52
      10HIGHLIGHTS OF PRESCRIBING INFORMATION  New onset or worsening renal impairment: Can include acute renal failure and Fanconi syndrome. Assess estimated creatinine

      HIGHLIGHTS OF PRESCRIBING INFORMATION  New onset or worsening renal impairment: Can include acute renal failure and Fanconi syndrome. Assess estimated creatinine

      Add to Reading List

      Source URL: www.gilead.com

      Language: English - Date: 2013-10-28 13:55:09